Skip to main content

Advertisement

ADVERTISEMENT

Medication Treatments

News
07/25/2016
Patient advocate Brenda Davis and Office of National Drug Control Policy (ONDCP) director Michael Botticelli are among this year's honorees from the American Association for the Treatment of Opioid Dependence (AATOD).
Patient advocate Brenda Davis and Office of National Drug Control Policy (ONDCP) director Michael Botticelli are among this year's honorees from the American Association for the Treatment of Opioid Dependence (AATOD).
Patient advocate Brenda Davis...
07/25/2016
Addiction Professional
News
07/18/2016
State officials in Pennsylvania believe a "hub-and-spoke" model emphasizing coordinated care and medication-assisted treatment will improve outcomes for Medicaid beneficiaries with opioid use disorders.
State officials in Pennsylvania believe a "hub-and-spoke" model emphasizing coordinated care and medication-assisted treatment will improve outcomes for Medicaid beneficiaries with opioid use disorders.
State officials in Pennsylvania...
07/18/2016
Addiction Professional
07/15/2016
The medical director of St. Louis-based Clayton Behavioral says more treatment providers need to embrace the evidence supporting medication treatments such as buprenorphine.
The medical director of St. Louis-based Clayton Behavioral says more treatment providers need to embrace the evidence supporting medication treatments such as buprenorphine.
The medical director of St....
07/15/2016
Addiction Professional
News
07/05/2016
A Husson University study of 2014 trends found that only 56% of a group of pharmacists reported accessing the state's prescription drug monitoring program (PDMP) database.
A Husson University study of 2014 trends found that only 56% of a group of pharmacists reported accessing the state's prescription drug monitoring program (PDMP) database.
A Husson University study of...
07/05/2016
Addiction Professional
06/28/2016
The National Safety Council states in a new report that only four states meet five of six indicators of progress in combating the opioid overdose crisis, with no states meeting all six criteria.
The National Safety Council states in a new report that only four states meet five of six indicators of progress in combating the opioid overdose crisis, with no states meeting all six criteria.
The National Safety Council...
06/28/2016
Addiction Professional
News
06/23/2016
Leaders at Casa Capri Recovery say the opioid crisis has driven their decision to open a six-bed women-only detox facility.
Leaders at Casa Capri Recovery say the opioid crisis has driven their decision to open a six-bed women-only detox facility.
Leaders at Casa Capri Recovery...
06/23/2016
Addiction Professional
News
06/17/2016
The recently approved six-month buprenorphine implant Probuphine showed greater efficacy than sublingual buprenorphine in data released this week.
The recently approved six-month buprenorphine implant Probuphine showed greater efficacy than sublingual buprenorphine in data released this week.
The recently approved six-month...
06/17/2016
Addiction Professional
News
05/27/2016
A six-month subdermal implant of the opioid treatment drug buprenorphine has received Food and Drug Administration (FDA) approval, and is being seen as an enhancement of medication-assisted treatment approaches.
A six-month subdermal implant of the opioid treatment drug buprenorphine has received Food and Drug Administration (FDA) approval, and is being seen as an enhancement of medication-assisted treatment approaches.
A six-month subdermal implant of...
05/27/2016
Addiction Professional
05/20/2016
A $3 million federal grant will fund the expansion of the opioid treatment-focused Providers' Clinical Support System for Medication Assisted Treatment initiative.
A $3 million federal grant will fund the expansion of the opioid treatment-focused Providers' Clinical Support System for Medication Assisted Treatment initiative.
A $3 million federal grant will...
05/20/2016
Addiction Professional
05/03/2016
An in-house pharmacy and a savings offer from a manufacturer are allowing Seabrook House to give doses of the opioid overdose reversal drug to discharged patients.
An in-house pharmacy and a savings offer from a manufacturer are allowing Seabrook House to give doses of the opioid overdose reversal drug to discharged patients.
An in-house pharmacy and a...
05/03/2016
Addiction Professional

Advertisement

Advertisement